Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...
The enforcement action is part of an escalating conflict between the FTC and the three pharmacy benefit managers that ...
Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
The FTC’s complaint, filed in its administrative court, accuses Express Scripts, Caremark Rx and Optum Rx of “abusing their ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The Federal Trade Commission on Friday sued prescription-drug middlemen owned by CVS Health Corp., Cigna Group and UnitedHealth Group Inc., alleging that they artificially pumped up prices of insulin ...